Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
TD Cowen Reiterates Hold Rating on 10X Genomics (TXG)
-
TD Cowen Downgrades 10X Genomics (TXG) to Hold
-
10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference
-
10x Genomics to Present at the 43rd Annual Cowen Healthcare Conference
-
Pre-Open Movers: Pinterest Gains on Elliott Stake, Solar Stocks Fall on Manchin
-
10x Genomics to Present at the Cowen 42nd Annual Health Care Conference
-
10x Genomics to Present at the 41st Annual Cowen Health Care Conference
-
10x Genomics to Present at the 41st Annual Cowen Health Care Conference
-
10x Genomics Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
10x Genomics Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
10x Genomics (TXG) Prices 4M Class A Share Upsized Common Offering at $110/Sh
-
10x Genomics Announces Pricing of Upsized Public Offering
-
10x Genomics Announces Pricing of Upsized Public Offering
-
10x Genomics (TXG) Announces Launch of 3.5M Share Follow-On Public Offering
-
10x Genomics Announces Launch of a Follow-On Public Offering
-
10x Genomics Announces Launch of a Follow-On Public Offering
-
10X Genomics (TXG) PT Raised to $100 at Cowen After Revenue Beats Despite Research Lab Closures
-
10x Genomics to Present at the 40th Annual Cowen Health Care Conference
-
10x Genomics to Present at the 40th Annual Cowen Health Care Conference
-
10X Genomics (TXG) PT Raised to $60 at Cowen
-
Cowen Starts 10X Genomics (TXG) at Outperform
-
10x Genomics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
10x Genomics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
10x Genomics, Inc. (TXG) Prices 10M Class A Share IPO at $39/Sh
-
10x Genomics Announces Pricing of Initial Public Offering

